These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6248183)

  • 21. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
    Faverly DR; Hendriks JH; Holland R
    Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Whole organ giant section histopathologic studies on breast cancer--I. Multi-centric lesions].
    Zhang ZD
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):356-8. PubMed ID: 1664316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast.
    Wobbes T; Tinnemans JG; van der Sluis RF
    Br J Surg; 1989 Feb; 76(2):185-6. PubMed ID: 2539223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma in situ of the breast.
    Carter D; Smith RR
    Cancer; 1977 Sep; 40(3):1189-93. PubMed ID: 198088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraductal breast carcinoma. Clinical, x-ray and histological findings and their therapeutic consequences].
    Bahnsen J; Warneke B; Frischbier HJ; Stegner HE
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):488-93. PubMed ID: 2993095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.
    Hwang ES; Kinkel K; Esserman LJ; Lu Y; Weidner N; Hylton NM
    Ann Surg Oncol; 2003 May; 10(4):381-8. PubMed ID: 12734086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive ductal carcinoma associated with tubular adenoma of the breast.
    Domoto H; Tsuda H; Miyakawa K; Shinoda A; Nanasawa T
    Pathol Int; 2002 Mar; 52(3):244-8. PubMed ID: 11972869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].
    Ruvalcaba-Limón E; de Jesús Garduño-Raya M; Bautista-Piña V; Trejo-Martínez C; Maffuz-Aziz A; Rodríguez-Cuevas S
    Cir Cir; 2014; 82(2):129-41. PubMed ID: 25312311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer multicentricity.
    McDivitt RW
    Monogr Pathol; 1984; (25):139-48. PubMed ID: 6330538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer.
    Ali-Mucheru M; Pockaj B; Patel B; Pizzitola V; Wasif N; Stucky CC; Gray R
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):649-655. PubMed ID: 27638679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histopathologic studies on whole organ giant section in breast cancer. II. Multicentricity and the chief primary lesion].
    Zhang ZD
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):345-7. PubMed ID: 1337889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical application of a color map pattern on shear-wave elastography for invasive breast cancer.
    Lee S; Jung Y; Bae Y
    Surg Oncol; 2016 Mar; 25(1):44-8. PubMed ID: 26979640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma.
    Lagios MD; Rose MR; Margolin FR
    Am J Clin Pathol; 1980 Jan; 73(1):25-30. PubMed ID: 6243440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apocrine Ductal Carcinoma In Situ Presenting as a Large, Cystic Breast Mass: An Uncommon Presentation of a Rare Breast Lesion.
    Seo KJ; Whang IY
    Breast J; 2017 Sep; 23(5):594-595. PubMed ID: 28252232
    [No Abstract]   [Full Text] [Related]  

  • 37. Staging and treatment of clinically occult breast cancer.
    Schwartz GF; Feig SA; Rosenberg AL; Patchefsky AS; Schwartz AB
    Cancer; 1984 Mar; 53(6):1379-84. PubMed ID: 6692326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis.
    Newstead GM; Baute PB; Toth HK
    Radiology; 1992 Sep; 184(3):623-7. PubMed ID: 1324506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma within fibroadenomas: mammographic features.
    Baker KS; Monsees BS; Diaz NM; Destouet JM; McDivitt RW
    Radiology; 1990 Aug; 176(2):371-4. PubMed ID: 2164233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
    Choi Y; Kim EJ; Seol H; Lee HE; Jang MJ; Kim SM; Kim JH; Kim SW; Choe G; Park SY
    Hum Pathol; 2012 Jan; 43(1):48-55. PubMed ID: 21733550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.